Remove Access Remove Policy Remove Safety Remove Therapy
article thumbnail

Arizona Senate Approves Bill That Could Legalize Therapeutic Psilocybin

Veriheal

Under the new measure, the Department of Human Services (DHS) will be able to offer licenses to psilocybin therapy centers with trained therapists and psychedelic facilitators. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62
article thumbnail

Veterans and Medical Cannabis: A Comprehensive Guide

MMJ Recs

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Webinar 9 December: Ethics, Safety, and Abuse in Psychedelic Medicine

Cannabis Law Report

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52
article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”.

Policy 52
article thumbnail

Press Release: Launch of the Psychedelic Access and Research European Alliance – PAREA

Cannabis Law Report

Those values guide our joint efforts to change perceptions about psychedelic assisted therapies, raise awareness of the scientific advances and, ultimately, bring better health to European citizens. Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD.

Access 52
article thumbnail

Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Cannabis Law Report

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59
article thumbnail

Press Release: Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

Cannabis Law Report

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.